Effects of nifedipine and interleukin-1α on the expression of collagen, matrix metalloproteinase-1, and tissue inhibitor of metalloproteinase-1 in human gingival fibroblasts

Journal of Periodontal Research

Volumn 41, Issue 4, 2006, Pages 266-272

  Sakagami, G ^a   Sato, E ^a   Sugita, Y ^a   Kosaka, T ^a   Kubo, K ^a   Maeda, H ^a   Kameyama, Y ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Interleukin 1 ; Matrix metalloprotinase 1; Nifedipine; Tissue inhbitor of metaltoproteinase 1

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; COLLAGEN TYPE 1; INTERLEUKIN 1; INTERSTITIAL COLLAGENASE; MESSENGER RNA; NIFEDIPINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADOLESCENT; ADULT; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; FIBROSIS; GINGIVA; HUMAN; MALE; METABOLISM; NONPARAMETRIC TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; COLLAGEN TYPE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; FIBROSIS; GINGIVA; HUMANS; INTERLEUKIN-1; MALE; MATRIX METALLOPROTEINASE 1; NIFEDIPINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 33748534795     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2006.00867.x     Document Type: Article

References (40)

1. Ferlinz J. Nifedipine in myocardial ischemia, systemic hypertension and other cardiovascular disorders. Ann Intern Med 1986;105:714-729.
2. Ramon Y, Behar S, Kistron Y, Engelberg IS. Gingival hyperplasia caused by nifedipine - a preliminary report. Int J Cardiol 1984;5:195-204.
3. Lucas RM, Howell LP, Wall BA. Nifedipine-induced gingival hyperplasia. A histochemical and ultrastructural study. J Periodontol 1985;56:211-215.
4. Barak S, Engelberg IS, Hiss J. Gingival hyperplasia caused by nifedipine. Histopathologic findings. J Periodontol 1987;58:639-642.
5. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996;23:165-175.
6. Hallmon WW, Rossmann JA. The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts. Periodontol 2000 1999;21:176-196.
7. Trackman PC, Kantarci A. Connective tissuemetabolism and gingival overgrowth. Crit Rev Oral Biol Med 2004;15:165-175.
8. Salo T, Oikarinen K.S, Oikarinen AI. Effect of phenytoin and nifedipine on collagen gene expression in human gingival fibroblasts. J Oral Pathol Med 1990;19:404-407.
9. Nishikawa S, Tada H, Hamasaki A et al. Nifedipine-induced gingival hyperplasia: a clinical and in vitro study. J Periodontol 1991;62:30-35.
10. Fujii A, Matsumoto H, Nakao S, Teshigawara H, Akimoto Y. Effect of calcium-channel blockers on cell proliferation, DNA synthesis and collagen synthesis of cultured gingival fibroblasts derived from human nifedipine responders and non-responders. Arch Oral Biol 1994;39:99-104.
11. Tipton DA, Fry HR, Dabbous MK. Altered collagen metabolism in nifedipineinduced gingival overgrowth. J Periodont Res 1994;29:401-409.
12. McKevitt K.MB, Irwin CR. Phenotypic differences in growth, matrix synthesis and response to nifedipine between fibroblasts derived from clinically healthy and overgrown gingival tissue. J Oral Pathol Med 1995;24:66-71.
13. Henderson JS, Flynn JC, Tucci MA et al. Site-specific variations in metabolism by human fibroblasts exposed to nifedipine in vitro. J Oral Pathol Med 1997;26:6-10.
14. Johnson RB, Zebrowski EJ, Dai X. Synergistic enhancement of collagenous protein synthesis by human gingival fibroblasts exposed to nifedipine and interleukin-1-beta In vitro. J Oral Pathol Med 2000;29:8-12.
15. Matsumoto H, Noji I, Akimoto Y, Fujii A. Comparative study of calcium-channel blockers on cell proliferation, DNA and collagen syntheses, and EGF receptors of cultured gingival fibroblasts derived from human nifedipine, nicardipine and nisoldipine responders. J Oral Sci 2001:43:261-268.
16. McCulloch CAG, Knowles GC. Deficiencies in collagen phagocytosis by human fibroblasts in vitro: a mechanism for fibrosis? J Cell Physiol 1993;155:461-471.
17. Kataoka M, Shimizu Y, Kunikiyo K. et al. Nifedipine induces gingival overgrowth in rats through a reduction in collagen phagocytosis by gingival fibroblasts. J Periodontol 2001;72:1078-1083.
18. Maita E, Sato M, Yamaki K. Effect of tranilast on matrix metalloproteinase-1 secretion from human gingival fibroblasts In vitro. J Periodontol 2004;75:1054-1060.
19. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitor of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92:827-839.
20. Reynolds JJ. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Oral Dis 1996:2:70-76.
21. Tipton DA, Stricklin GP, Dabbous MK. Fibroblast heterogeneity in collagenolytic response to cyclosporine. J Cell Biochem 1991;46:152-165.
22. Yamada H, Nishimura F, Naruishi K et al. Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts. J Periodontol 2000;71:933-960.
23. Tüter G, Serdar MA, Yalim M, Gürham IS, Balos K. Evaluation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 levels in gingival fibroblasts of cyclosporin A-treated patients. J Periodontol 2000;73:1273-1278.
24. Hyland PL, Traynor PS, Myrillas TT et al. The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts. J Periodontol 2003;74:437-445.
25. Nery EB, Edson RG, Lee KK, Pruthi VK, Watson J. Prevalence of nifedipine-induced gingival hyperplasia. J Periodontol 1995;66:572-578.
26. Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study. J Periodontol 1999;70:63-67.
27. Miranda J, Brunet L, Roset P, Berini L, Farré M, Mendieta C. Prevalence and risk of gingival enlargement in patients treated with nifedipine. J Periodontol 2001;72:605-611.
28. Ishihara Y, Nishihara T, Kuroyanagi T et al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodont Res 1997;32:524-529.
29. Sfakianakis A, Barr CE, Kreutzer DL. Actinohacillus actinomycetemcomitans-induced expression of IL-1α and IL-1β in human gingival epithelial eel Is: role in IL-8 expression. Eur J Oral Sci 2001;109:393-401.
30. Hayakawa T, Yamashita K., Tanzawa K, Uchijima E, Iwata K. Growth-promoting activity of tissue inhibitor of metalloprotainases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992;298:29-32.
31. Ellis JS, Seymour RA, Monkman S, Idle JR. Disposition of nifedipinein plasma and gingival crevicular fluid in relation to druginduced gingival overgrowth. J Periodont Res 1993;28:373-378.
32. Domeij H, Modeer T, Yucel-Lindberg T. Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 production in human gingival fibroblasts: the role of protein kinase C. J Periodont Res 2004:39:308-314.
33. Uzel MI, Kantorei A, Hong H-H et al. Connective tissue growth factor in druginduced gingival overgrowth. J Periodentol 2001:72:921-931.
34. Henry MT, McMahon K, Mackarel AJ et al. Matrix metalloproteinase and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IFF. Eur Respir J 2002:20:1220-1227.
35. Strup-Perrot C, Mathé D, Linard C et al Global gene expression profiles reveal an increase in mRNA levels of collagens, MMPs, and TIMPs in late radiation enteritis. Am J Physiol Gastrointest Liver Physiol 2004;287:G875-G885.
36. Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cordiol 2004;44:1609-1618.
37. Tüter G, Kurtis B, Serdar M. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1. J Periodontol 2002:73:487-493.
38. 2microglobulin induces MMP-1 but not TIMP-1 expression in human synovial fibroblasts. Kidney Int 2000:57:2023-2034.
39. Ninomiya T, Yoon S, Nagano H et al. Significance of serum matrix metalloproteinases and their inhibitors on the antifibrogenetic effect of interferon-alfa in chronic hepatitis C patients. Intervirology 2001;44:227-231.
40. van der Zee E, Everts V, Hoeben K, Beertsen W. Immunolocalisation of collagenase in rabbit periosteal tissue expiants and extraction of the enzyme. The effect of the cytokines IL-1α and EGF. J Cell Sci 1994;107:1047-1053.